ImmunoMolecular Therapeutics, Inc. — Form D
ImmunoMolecular Therapeutics, Inc. of Woburn, MA, a company, filed a Form D exempt-offering notice with the SEC on 2019-06-19. The offering totals $10.0M, of which $3.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2019-06-19
- Form: D
- Accession: 0001646606-19-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $10.0M
- Amount sold: $3.0M
- Remaining: $7.0M
- Investors: 7
- Date of first sale: 2019-06-04
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-342324
Issuer
- Name: ImmunoMolecular Therapeutics, Inc.
- CIK: 0001646606
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 299 Washington Street, Woburn, MA, 01801
- Phone: (303) 544-2104
Officers, directors & promoters (16)
| Name | Role | Location |
|---|
| Jonathan Behr | Director | London, X0 |
| Peter Gottlieb | Promoter | Woburn, MA |
| Aaron Michels | Promoter | Woburn, MA |
| Ed Orr | Promoter | Woburn, MA |
| Jason Dinges | Director | New Canaan, CT |
| Sean Doherty | Director | New York, NY |
| Peter Gottlieb | Director | Woburn, MA |
| Peter Gottlieb | Executive Officer | Woburn, MA |
| Ed Orr | Director | Woburn, MA |
| Tom Shea | Executive Officer | Woburn, MA |
| Aaron Michels | Executive Officer | Woburn, MA |
| Nandan Padukone | Director | Woburn, MA |
| Nandan Padukone | Executive Officer | Woburn, MA |
| Steve Orndorff | Director | Aurora, CO |
| Steve Orndorff | Executive Officer | Aurora, CO |
| Steve Orndorff | Promoter | Aurora, CO |
Other filings by this issuer (3)
More